Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NETWORK × Inoperable œsophageal Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 25 Ovarian Neoplasms 23 Breast Neoplasms 22 Lung Neoplasms 19 Lymphoma 18 Carcinoma, Ovarian Epithelial 18 Neoplasm Metastasis 14 Colorectal Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 12 Sarcoma 12 Head and Neck Neoplasms 12 Urinary Bladder Neoplasms 10 Prostatic Neoplasms 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Multiple Myeloma 9 Central Nervous System Neoplasms 9 Astrocytoma 9 Uterine Cervical Neoplasms 8 Mycosis Fungoides 8 Fallopian Tube Neoplasms 8 Adenocarcinoma of Lung 8 Stomach Neoplasms 7 Recurrence 7 Oligodendroglioma 7 Melanoma 7 Sezary Syndrome 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Medulloblastoma 6 Lymphoma, T-Cell, Cutaneous 6

Interventions

Nivolumab 1 Ipilimumab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡